How to approach a medicines query relating to breastfeeding
Questions regarding a medicine’s suitability for breastfeeding mothers are often directed at pharmacists. Two MI pharmacists who specialise in this field share their approach to addressing such queries
When a breastfeeding mother requires pharmacological treatment, the risk of exposing the infant to the medicine via breast milk should be assessed.
The risk of exposure is determined by taking into account the age (actual or gestational) of the infant and any comorbidities or concurrent treatment. Several strategies can be used to minimise the accumulation of medicines in breast milk.
Elena Grant is senior medicines information pharmacist for West Midlands Medicines Information Service. Peter Golightly is director of the UK Drugs in Lactation Information and Advisory Service.
NOTE Clinical Pharmacist PRACTICE TOOLS do not constitute formal practice guidance. Articles in the series have been commissioned from independent authors who have summarised useful clinical skills.
Call for PRACTICE TOOLS
Useful clinical skills are described in this Clinical Pharmacist series. Comments on this or other articles are welcomed in the form of personal feedback to the editor or correspondence to Clinical Pharmacist. Pharmacists who have ideas for the series or wish to write an article are invited to contact the editor.
Telephone: +44 (0)20 7572 2425
Citation: Clinical Pharmacist URI: 11004822
Recommended from Pharmaceutical Press